Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F1V48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,392
Award facts
- Contract value 100% obligated
- $17,391.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,391.82 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on January 15, 2026, with completion scheduled for January 16, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, supporting the military healthcare supply chain's need for specialized pharmaceutical products.
This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive single-award IDC enables Cencora to supply a broad portfolio of pharmaceutical products, medical supplies, and specialty medications to support military treatment facilities and veteran healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor and critical federal healthcare vendor, regularly fulfills delivery orders under this vehicle for medications spanning multiple therapeutic domains including oncology, rheumatology, and pain management.
Quick answers
Who was awarded contract SPE2DR26F1V48?
SPE2DR26F1V48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1V48 worth?
The government has obligated $17,392 on SPE2DR26F1V48.
Is contract SPE2DR26F1V48 an order under another contract?
Yes. SPE2DR26F1V48 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1V48 competed?
The extent of competition for SPE2DR26F1V48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award